NCT00993109View on ClinicalTrials.gov

Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Hypertension
Interventions
DRUG

Adalat (Nifedipine, BAYA1040)

Nifedipine GITS/OROS 30 mg OM + Valsartan 80 mg OM

DRUG

Diovan (Valsartan)

Valsartan 160 mg OM (Two Valsartan 80mg tablets)

Trial Locations (17)

100029

Beijing

100037

Beijing

110001

Shenyang

200025

Shanghai

210008

Nanjing

210029

Nanjing

410008

Changsha

410013

Changsha

501757

Donggu

510080

Guangzhou

050051

Shijiazhuang

Unknown

Bucheon-si

Yangsan

Jongno-gu

Junggu

110-744

Seoul

120-752

Seoul

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY